$38.00
-0.07[-0.18%]
At close: Apr 26
$38.00
0[0.00%]
After Hours: 5:17PM EDT
Inari Medical
(NASDAQ:NARI)Inari Medical Stock (NASDAQ:NARI), Analyst Ratings, Price Targets, Predictions
Inari Medical Inc has a consensus price target of $82.73, established from looking at the 38 latest analyst ratings. The last 3 analyst ratings were released from Canaccord Genuity, Truist Securities, and Needham on April 12, 2024, March 22, 2024, and March 6, 2024. With an average price target of $66.33 between Canaccord Genuity, Truist Securities, and Needham, there's an implied 74.56% upside for Inari Medical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Truist Securities
Needham
Piper Sandler
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Inari Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | NARI | Buy Now | Inari Medical | $38.00 | 97.37% | Canaccord Genuity | William Plovanic | $75 → $75 | Maintains | Buy | Get Alert |
| 03/22/2024 | NARI | Buy Now | Inari Medical | $38.00 | 36.84% | Truist Securities | Richard Newitter | $61 → $52 | Maintains | Hold | Get Alert |
| 03/06/2024 | NARI | Buy Now | Inari Medical | $38.00 | 89.47% | Needham | Mike Matson | → $72 | Reiterates | Buy → Buy | Get Alert |
| 02/29/2024 | NARI | Buy Now | Inari Medical | $38.00 | 89.47% | Needham | Mike Matson | → $72 | Reiterates | Buy → Buy | Get Alert |
| 02/29/2024 | NARI | Buy Now | Inari Medical | $38.00 | 60.53% | Truist Securities | Richard Newitter | $63 → $61 | Reiterates | Hold → Hold | Get Alert |
| 02/29/2024 | NARI | Buy Now | Inari Medical | $38.00 | 44.74% | Piper Sandler | Adam Maeder | $85 → $55 | Downgrade | Overweight → Neutral | Get Alert |
| 02/29/2024 | NARI | Buy Now | Inari Medical | $38.00 | 97.37% | Canaccord Genuity | William Plovanic | $79 → $75 | Maintains | Buy | Get Alert |
| 01/23/2024 | NARI | Buy Now | Inari Medical | $38.00 | 89.47% | Needham | Mike Matson | → $72 | Initiates | → Buy | Get Alert |
| 12/22/2023 | NARI | Buy Now | Inari Medical | $38.00 | 84.21% | Truist Securities | Richard Newitter | $65 → $70 | Maintains | Hold | Get Alert |
| 11/03/2023 | NARI | Buy Now | Inari Medical | $38.00 | 71.05% | Truist Securities | Richard Newitter | $60 → $65 | Maintains | Hold | Get Alert |
| 11/02/2023 | NARI | Buy Now | Inari Medical | $38.00 | 123.68% | Piper Sandler | Adam Maeder | $90 → $85 | Maintains | Overweight | Get Alert |
| 08/03/2023 | NARI | Buy Now | Inari Medical | $38.00 | 118.42% | Morgan Stanley | Cecilia Furlong | $83 → $83 | Reiterates | Overweight → Overweight | Get Alert |
| 07/19/2023 | NARI | Buy Now | Inari Medical | $38.00 | 71.05% | Truist Securities | Richard Newitter | $70 → $65 | Maintains | Hold | Get Alert |
| 07/19/2023 | NARI | Buy Now | Inari Medical | $38.00 | 107.89% | Baird | David Rescott | → $79 | Initiates | → Outperform | Get Alert |
| 05/04/2023 | NARI | Buy Now | Inari Medical | $38.00 | 121.05% | Canaccord Genuity | William Plovanic | $80 → $84 | Maintains | Buy | Get Alert |
| 04/18/2023 | NARI | Buy Now | Inari Medical | $38.00 | 84.21% | Truist Securities | Richard Newitter | $68 → $70 | Maintains | Hold | Get Alert |
| 02/28/2023 | NARI | Buy Now | Inari Medical | $38.00 | 110.53% | Canaccord Genuity | William Plovanic | $77 → $80 | Maintains | Buy | Get Alert |
| 02/21/2023 | NARI | Buy Now | Inari Medical | $38.00 | 102.63% | Canaccord Genuity | William Plovanic | $76 → $77 | Maintains | Buy | Get Alert |
| 01/31/2023 | NARI | Buy Now | Inari Medical | $38.00 | 71.05% | Truist Securities | Richard Newitter | $75 → $65 | Maintains | Hold | Get Alert |
FAQ
What is the target price for Inari Medical (NARI)?
The latest price target for Inari Medical (NASDAQ: NARI) was reported by Canaccord Genuity on April 12, 2024. The analyst firm set a price target for $75.00 expecting NARI to rise to within 12 months (a possible 97.37% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inari Medical (NARI)?
The latest analyst rating for Inari Medical (NASDAQ: NARI) was provided by Canaccord Genuity, and Inari Medical maintained their buy rating.
When was the last upgrade for Inari Medical (NARI)?
There is no last upgrade for Inari Medical.
When was the last downgrade for Inari Medical (NARI)?
The last downgrade for Inari Medical Inc happened on February 29, 2024 when Piper Sandler changed their price target from $85 to $55 for Inari Medical Inc.
When is the next analyst rating going to be posted or updated for Inari Medical (NARI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inari Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inari Medical was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Inari Medical (NARI) correct?
While ratings are subjective and will change, the latest Inari Medical (NARI) rating was a maintained with a price target of $75.00 to $75.00. The current price Inari Medical (NARI) is trading at is $38.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.